ArticleCardiovascular and interventional radiology2025
Impact of Diameter Mismatch Between the Inflow Vein and Stent on Patency in Thrombotic Iliac Vein Lesions.
Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the impact of post-stent placement inflow vein diameter on iliac vein stent patency in patients with thrombotic iliac vein lesions.
methodsThis is a single-center retrospective study examining consecutive patients who received primary iliac vein stent placement between January 2014 and February 2024. Inflow vein to stent diameter mismatch (ISM) was defined as the mismatch percentage of narrowed adjacent vein (NAV) diameter to stent peripheral edge diameter. The receiver operator characteristic (ROC) curve was used to assess the predictive performance of NAV and ISM on stent patency loss. Cox regression models were used to determine the predictive factors for stent patency loss. Restricted cubic spline (RCS) was used to assess the association between ISM and patency loss on a continuous scale.
resultsSeventy-three patients with 77 limbs (acute deep vein thrombosis, n = 44; post-thrombotic syndrome, n = 33) were included. During a median follow-up of 22.9 months (IQR 5.6-50.4 months), the primary stent patency rate was 67.5%. ISM had a satisfactory predictive performance (area under curve = 0.85) for stent patency loss. NAV < 6.5 mm (adjusted HR 3.01; p = .009) and ISM > 21.8% (adjusted HR 6.69; p = .001) were significantly associated with an increased risk of stent patency loss. RCS revealed that an increasing ISM was consistently associated with an increasing risk of patency loss (p = .005).
conclusionNAV and ISM by venography at the time of stent placement for thrombotic iliac vein lesions may be associated with patency loss. LEVEL OF EVIDENCE: Level 4, Case Series.
Indexed as
Identifiers
41131431What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.